Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon gamma.
Open Access
- 1 June 1989
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 169 (6), 2257-2262
- https://doi.org/10.1084/jem.169.6.2257
Abstract
Plasma samples obtained from patients receiving a 24-h continuous infusion of human recombinant (hr)TNF or a combination of two overlapping, 24-h continuous infusions of hrIFN-gamma and hrTNF were analyzed for IL-6 in a sensitive bioassay. A transient appearance of circulating IL-6 was observed with peak levels between 3 and 6 h after the start of the hrTNF infusion. These peak levels correlated quite well with the dose of hrTNF administered (r = 0.86; p less than 0.001). The maximal value observed was 27.5 ng/ml IL-6 in a sample of a patient receiving 545 micrograms/m2 hrTNF. The combination of hrIFN-gamma (200 micrograms/m2) and hrTNF in the infusions resulted in higher IL-6 levels than a comparable dose of hrTNF alone. A maximal value of 23.5 ng/ml IL-6 was observed in a patient receiving 205 micrograms/m2 hrTNF. No IL-6 was found in the plasma of patients during the 12-h infusion with hrIFN-gamma alone, except for two borderline samples.This publication has 10 references indexed in Scilit:
- PHASE-I STUDY OF 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION OF RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR1988
- Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic StudyJNCI Journal of the National Cancer Institute, 1988
- Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings.1988
- Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice.The Journal of Experimental Medicine, 1988
- Multiple actions of interleukin 6 within a cytokine networkImmunology Today, 1988
- Cachectin: A Hormone that Triggers Acute Shock and Chronic CachexiaThe Journal of Infectious Diseases, 1988
- Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.Proceedings of the National Academy of Sciences, 1986
- In vivo anti‐tumour activity of recombinant human and murine TNF, alone and in combination with murine IFN‐γ, on a syngeneic murine melanomaInternational Journal of Cancer, 1986
- Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigensJournal of Immunological Methods, 1984